Pancreatic safety of DPP-4 inhibitors in type 2 diabetes millitus A protocol for systematic review and network meta-analysis

Yang, F; Dong, YZ; Li, BH; Ning, BB; Zhao, QL

Zhao, QL (通讯作者)，Shandong Univ Tradit Chinese Med, Affiliated Hosp, Jinan 250014, Shandong, Peoples R China.

MEDICINE, 2022; 101 (17):

Abstract

Background: Dipeptidyl-peptidase IV inhibitor (DPP-4i) is a common hypoglycemic medication in treating type 2 diabetes millitus. It has become widely ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索